ATAC-seq of P2 mouse epithelial and non-epithelial cochlear cells
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA521063 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR8535104_1.fastq.gz | Fastqsanger.gz | |||
| SRR8535104_2.fastq.gz | Fastqsanger.gz | |||
| SRR8535105_1.fastq.gz | Fastqsanger.gz | |||
| SRR8535105_2.fastq.gz | Fastqsanger.gz | |||
| SRR8535106_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 8 |
Similar Datasets
Project description:To identify gene regulatory regions in the cochlea, we FACS-sorted biological duplicates of epithelial cells (CD326+; including hair cells and supporting cells) and non-epithelial cells (CD326-; predominantly mesenchymal cells) from mouse cochlea at postnatal day 2 and performed ATAC-seq to identify open chromatin regions in each cell type. CD-1 timed-pregnant females were purchased from Charles River (Maryland). At postnatal day 2, the mice were euthanized and their temporal bone removed. Cochlear ducts from 20 mice were harvested, pooled and processed for Fluorescence-activated cell sorting (FACS). Briefly, single-cell suspensions were obtained and incubated with an APC-conjugated anti-CD326 (1:2000, BioLegend) to label epithelial cells. Cells were sorted into cochlear CD326 (+) cells (epithelial) and cochlear CD326 (-) cells (non-epithelial) by FACS using a BD FACS Aria II Cell Sorter (BD Biosciences) at the Flow Cytometry Facility, Center for Innovative Biomedical Resources (University of Maryland School of Medicine). 50,000 cells or 100,000 cells from each sample were further processed for ATAC-seq as described (Buenrostro et al. 2015. Curr. Prot. Mol. Med.) with the following modification: following the transposition reaction and purification step, a right side size selection (ratio 0.6) using SPRIselect (Beckman-Coulter, Indiana) was added before proceeding to the PCR amplification. This extra step resulted in the selection of DNA fragments between 150 bp to 700 bp.
2019-08-02 | GSE126129 | GEO
Project description:Purpose and Methods: Cochlear sensory hair cells (HCs) are essential for our sense of hearing. They are embedded in the organ of Corti that lacks regenerative capacity, which is a major cause of hearing loss. However, some neonatal non-sensory cells in the organ of Corti display a limited regenerative ability. We used fluorescence-activated cell sorting (FACS) to isolate different cochlear cell types from postnatal day 2 (P2) mice to assess the individual cell groups’ potential to grow organoids and to generate new HCs. Single-cell RNAseq validated the composition of the cell types in the sorted cell groups. Results and Conclusions: The greater epithelial ridge (GER), a transient tissue that only exists in the neonatal inner ear, harbored the most potent organoid-forming cells. GER-derived organoids expanded into large colonies when cultured adherently and gave rise to new hair cell marker-expressing cells in a sensory epithelia-resembling organization. The organoid forming ability of GER cells was synergistically enhanced when they were cultured at increasing density. The synergistic effect relied on direct cell-to-cell contact rather than released soluble factors.
2020-12-29 | GSE162308 | GEO
Project description:Age-related hearing impairment (ARHI), one of the most common medical conditions, is strongly heritable, yet its genetic causes remain largely unknown. We conducted a meta-analysis of GWAS summary statistics from multiple hearing-related traits in the UK Biobank (n = up to 323,978) and identified 31 genome-wide significant risk loci for self-reported hearing difficulty (p < 5e-8), of which 30 have not been reported previously at genome-wide significance. We interpreted these loci in the context of newly generated ATAC-seq and single-cell RNA-seq from cells in the mouse cochlea. Risk-associated genes were enriched for expression in cochlear epithelial and non-epithelial cells, as well as for genes related to sensory perception and known Mendelian deafness genes, supporting their relevance to auditory function. Regions of the human genome homologous to open chromatin in sensory epithelial cells from the mouse were strongly enriched for heritable risk for hearing difficulty, even after adjusting for baseline effects of evolutionary conservation and cell-type non-specific regulatory regions. Epigenomic and statistical fine-mapping most strongly supported 50 putative risk genes. Of these, at least 45 were expressed in mouse cochlea and 15 were enriched specifically in sensory hair cells. These results reveal new risk loci and risk genes for hearing difficulty and suggest an important role for altered gene regulation in the cochlear sensory epithelium.
2020-08-01 | GSE135737 | GEO
Project description:We screened proteins in close proximity to PI(4,5)P2 in epithelial cells. We established HaCaT cells stably expressing APEX2 N-terminally fused to the PH domain of PLCd1, which specifically binds to PI(4,5)P2. In the presence of hydrogen peroxide and biotin-phenol, proteins proximal to APEX2 are biotinylated by APEX2, allowing for their enrichment using streptavidin beads. APEX2-fused non-PI(4,5) P2-binding mutant of the PH domain of PLCd1 (R40L) was used as the negative control.
2022-03-26 | PXD031266 | Pride
Project description:ATAC-seq of human non-tumourigenic breast epithelial cell line MCF10A
| PRJEB41673 | ENA
Project description:The cochlear nucleus is the first central pathway involved in the processing of peripheral auditory activity. It is heterogeneous in neuronal populations and physiologic responses and is organized in three major subdivisions: the anterior ventral cochlear nucleus (AVCN), the posterior ventral cochlear nucleus (PVCN) and the dorsal cochlear nucleus (DCN). Although each region demonstrates multiple cell types and functions, there are predominant populations of neurons in each region that underlie the principal role each subdivision plays in auditory processing. Little is known of the underlying genetic contribution to these properties. This study sought to identify genes expressed in the subdivisions of the cochlear nucleus that may account for the anatomical and physiological characteristics of each subdivision. These data provide a genetic basis for understanding normal auditory processing in the cochlear nucleus and a template for investigating changes that may occur with hearing loss, the generation and percept of tinnitus, and central processing disorders. Keywords: normal, comparative Brown Norway rats (n=40, female, 45days) were anesthetized and decapitated. Brains were rapidly removed and the subdivisions of the cochlear nucleus (AVCN, PVCN and DCN) dissected on dry ice. Total RNA was extracted and tested for concentration and purity by spectrophotometry and integrity by gel electrophoresis. SAGE was performed using the NlaIII enzyme and Invitrogen SAGE kit. Concatemers were commercially sequenced and imported into eSAGE (Margulies and Innis, 2000) for tag extraction and frequency.
2005-12-31 | E-GEOD-3628 | biostudies-arrayexpress
Project description:Rhodopirellula sp. P2 strain:P2 Genome sequencing
| PRJNA932611 | ENA
Project description:Paracoccus sp. P2 strain:P2 Genome sequencing
| PRJNA1150278 | ENA
Project description:Lung epithelial cell ATAC G9ai
| PRJNA964591 | ENA
Project description:This study investigates how lead exposure triggers cochlear synaptopathy and hearing loss in mice. Young-adult CBA/J mice were given lead acetate in drinking water for 28 days. We assessed hearing thresholds, outer hair cell activity, and synaptic changes in the cochlea. Lead exposure raises hearing thresholds, indicating cochlear synaptopathy. Notably affects synapses in the basal turn without impacting outer hair cells. In addition to this, lead altered the abundance of 352 synaptic proteins, with the synaptic vesicle cycle pathway prominently affected. Lead-induced cochlear synaptopathy targets basal cochlear regions, implicating synaptic vesicle cycle signaling in hearing loss. Revealing specific mechanisms behind lead-induced hearing deficits enhances targeted interventions and preventive strategies, advancing our understanding of lead induced hearing loss.
2024-10-17 | PXD050415 | Pride